BridgeMD
New treatment option for Cruciate Ligament Reconstruction
Official title Comparison of Tendon and Muscle-Tendon Semitendinosus Grafts After ACL Reconstruction
ClinicalTrials.gov ID: NCT07404046
What this study is testing
- What it's testing
- Aim: Comparison of tendon to bone ingrowth in bone tunnels and intra-articular remodeling of the graft after anterior cruciate ligament surgery with a muscle-tendon graft and those with a tendon graft. Subjects and methods: It is a single-blind prospective randomized study that would include at least 40 patients with an anterior cruciate ligament rupture.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 50
You may be able to join if
- Clinically and radiologically confirmed anterior cruciate ligament (ACL) rupture.
- Age between 18 and 50 years.
- Intact posterior cruciate ligament and collateral ligaments.
- Signed informed consent to participate in the study.
- Patients meeting at least one indication for concomitant lateral tenodesis, including: age under 25 years, positive pivot-shift test, presence of...
You likely can't join if
- Previous ACL reconstruction of the same knee.
- Inability to use a graft prepared by quadruple folding of the semitendinosus tendon.
- Graft diameter \< 7.5 mm.
- MRI-confirmed unsuccessful meniscal healing after repair.
- Acute joint infection or history of joint infection.
The study team makes the final eligibility decision.
Where it's taking place
- Zagreb, Croatia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 50 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Zagreb, Croatia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.